Yoav Manaster

Yoav Manaster started their work experience in 2015 as the CEO of Progenetics, a company that specializes in providing cutting-edge Onco-Diagnostic services. During their time there, they represented various renowned organizations such as Caris Life Sciences, Natera, Decipher Biosciences, Biotheranostics, and OPKO. In 2019, they became a Co-Founder of EdiTy Therapeutics.

Yoav Manaster completed their education in the field of Tumor Immunology, earning a Doctor of Philosophy (Ph.D.) degree from the Weizmann Institute of Science. Yoav pursued their doctoral studies from 2007 to 2011, focusing on tumor immunology. The specific details surrounding their completion or enrollment status beyond 2011 are not provided.